LEASE AGREEMENTLease Agreement • March 9th, 2021 • Regulus Therapeutics Inc. • Pharmaceutical preparations
THIS LEASE AGREEMENT (this “Lease”) is made this 11th day of February, 2021, between ARE-SD REGION NO. 58, LLC, a Delaware limited liability company (“Landlord”), and REGULUS THERAPEUTICS INC., a Delaware corporation (“Tenant”).
ContractEmployment Agreement • March 9th, 2021 • Regulus Therapeutics Inc. • Pharmaceutical preparations • California
241684614 v6 2 California (the “New Premises”) in the condition required under that certain lease agreement (the “New Lease”) to be entered into between Assignor and the New Landlord (such date, the “New Lease Delivery Date”). 3. Assumption of Lease....Assignment and Assumption of Lease • March 9th, 2021 • Regulus Therapeutics Inc. • Pharmaceutical preparations • California
SECOND AMENDMENT TO LOAN AND SECURITY AGREEMENTLoan and Security Agreement • March 9th, 2021 • Regulus Therapeutics Inc. • Pharmaceutical preparations • California
THIS SECOND AMENDMENT to Loan and Security Agreement (this “Amendment”) is made effective as of March 6, 2018 (the “Second Amendment Date”) and made, by and among OXFORD FINANCE LLC, a Delaware limited liability company with an office located at 133 North Fairfax Street, Alexandria, Virginia 22314 (in its individual capacity, “Oxford”; and in its capacity as Collateral Agent, “Collateral Agent”), the Lenders listed on Schedule 1.1 of the Loan Agreement (as defined below) from time to time including Oxford in its capacity as a Lender (each a “Lender” and collectively, the “Lenders”) and REGULUS THERAPEUTICS INC., a Delaware corporation with offices located at 10614 Science Center Dr., San Diego, California 92121 (“Borrower”).
